Effects of Vitamin D on blood pressure in patients with type 2 diabetes mellitus

International Journal of Clinical Pharmacology and Therapeutics

Volumn 54, Issue 4, 2016, Pages 233-242

  Lee, Kyeong Ju ^a   Lee, Yu Jeung ^a  

^a Kangwon National University   (South Korea)

Author keywords

Blood pressure; Meta analysis; Systematic review; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; PARICALCITOL; PLACEBO; VITAMIN D;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; BLOOD PRESSURE; DIETARY SUPPLEMENT; DRUG EFFECTS; PATHOPHYSIOLOGY;

BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D;

EID: 84966373453     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP202493     Document Type: Article

References (44)

1. Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, Larijani B. Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. Daru. 2012; 20: 10.
2. Eliades M, Pittas AG. Vitamin D and type 2 diabetes. Clin Rev Bone Miner Metab. 2009; 7: 185-198.
3. Reichel H, Koeffler H P, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989; 320: 980-991.
4. Holick M F, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87: 1080S-1086S.
5. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008; 52: 1949-1956.
6. Holick MF Vitamin D defiiciency. N Engl J Med. 2007; 357: 266-281.
7. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM, Hewison M. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002; 13: 621-629.
8. Wang TJ, Pencina MJ, Booth SL, Jacques P F, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117: 503-511.
9. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007; 167: 1159-1165.
10. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006; 92: 39-48.
11. Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005; 63: 493-498.
12. Judd SE, Raiser SN, Kumari M, Tangpricha V. 1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol. 2010; 121: 445-447.
13. Goel RK, Lal H. Role of vitamin d supplementation in hypertension. Indian J Clin Biochem. 2011; 26: 88-90.
14. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006; 84: 18-28.
15. Al-Zaharani M. The prevalence of vitamin D deficiency in type 2 diabetic patients. Majmaah J Health Sci. 2013; 1: 24-28.
16. Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care. 2006; 29: 174.
17. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving H-H, Pritchett Y, Remuzzi G, Ritz E, Andress D. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010; 376: 1543-1551.
18. Jehle S, Lardi A, Felix B, Hulter HN, Stettler C, Krapf R. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study. Swiss Med Wkly. 2014; 144: w13942.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1-12.
20. Khoshdel A, Attia J, Carney SL. Basic concepts in meta-analysis: A primer for clinicians. Int J Clin Pract. 2006; 60: 1287-1294.
21. Ahmadi N, Mortazavi M, Iraj B, Askari G. Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients? J Res Med Sci. 2013; 18: 374-377.
22. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. 2013; 32: 970-975.
23. Breslavsky A, Oz H, Matas Z, Shargorodsky M. The effect of vitamin D supplementation on plasma leptin/adiponectin ratio in diabetic individuals with different haptoglobin phenotypes. Cardiovasc Endocrinol. 2014; 3: 74-78.
24. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009; 48: 349-354.
25. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. Metabolism. 2014; 63: 1115-1124.
26. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, Salekzamani S, Zahedirad M. Daily consumption of vitamin D-or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr. 2011; 93: 764-771.
27. Ryu OH, Chung W, Lee S, Hong KS, Choi MG, Yoo HJ. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med. 2014; 29: 620-629.
28. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, Kalayi A, Shariatzadeh N, Zahedirad M, Khalaji N, Haidari H. Regular consumption of vitamin Dfortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med. 2011; 9: 125.
29. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008; 25: 320-325.
30. Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia. 2014; 57: 2038-2047.
31. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010; 53: 2112-2119.
32. Yiu Y-F, Yiu K-H, Siu C-W, Chan Y-H, Li S-W, Wong L-Y, Lee S W, Tam S, Wong EW, Lau C-P, Cheung BM, Tse HF. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis. 2013; 227: 140-146.
33. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151: 264-269.
34. Zabihiyeganeh M, Jahed A, Nojomi M. Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oral vs intramuscular; an open labeled RCT. Clin Endocrinol (Oxf). 2013; 78: 210-216.
35. Kant KS, Gonzalez AR, Hariachar S, Bernardo M, Duggal A, Engstrand S, Hunter J, Plone M, Hertel J. Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol. J Ren Nutr. 2012; 22: 34-40.e2.
36. Qiao G, Kong J, Uskokovic M, Li YC. Analogs of 1α,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis. J Steroid Biochem Mol Biol. 2005; 96: 59-66.
37. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007; 282: 29821-29830.
38. Bouillon R, Van Cromphaut S, Carmeliet G. Intestinal calcium absorption: Molecular vitamin D mediated mechanisms. J Cell Biochem. 2003; 88: 332-339.
39. Soubassi L P, Chiras TC, Papadakis ED, Poulos GD, Chaniotis DI, Tsapakidis I P, Soubassi S P, Zerefos SN, Zerefos NS, Valis DA. Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis. Int Urol Nephrol. 2006; 38: 795-800.
40. Chiu KC, Chu A, Go V LW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004; 79: 820-825.
41. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007; 71: 134-139.
42. Almarhoumi L F, Al Kadi H. Vitamin D levels and its relation to blood pressure among Saudi post-menopausal women: a cross-sectional study. Life Sci J. 2014; 11: 342-346.
43. Abiodun AG, Egwu MO, Adedoyin RA. Anthropometric indices associated with variation in cardiovascular parameters among primary school pupils in Ile-Ife. Int J Hypertens. 2011; 2011: 186194.
44. Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles D W, Morley R, Parkington HC. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol. 2011; 589: 4777-4786.